Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000877806 | SCV001020595 | benign | Developmental and epileptic encephalopathy, 32 | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001354563 | SCV004124201 | benign | not provided | 2022-10-01 | criteria provided, single submitter | clinical testing | KCNA2: BS1, BS2 |
Breakthrough Genomics, |
RCV001354563 | SCV005280336 | benign | not provided | criteria provided, single submitter | not provided | ||
Department of Pathology and Laboratory Medicine, |
RCV001354563 | SCV001549210 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The KCNA2 p.Ser324Ser variant was not identified in the literature nor was it identified in ClinVar, Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs765820644) and in 55 of 251360 chromosomes at a frequency of 0.000219 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: South Asian in 46 of 30614 chromosomes (freq: 0.001503), Ashkenazi Jewish in 4 of 10078 chromosomes (freq: 0.000397), Other in 1 of 6132 chromosomes (freq: 0.000163) and European (non-Finnish) in 4 of 113730 chromosomes (freq: 0.000035); it was not observed in the African, Latino, East Asian and European (Finnish) populations. The p.Ser324Ser variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. Further, in silico or computational prediction software programs, (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a significance difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |